A pharmacy benefit manager (PBM) audit is a civil, contractual review, but it can also be where a criminal healthcare fraud case against a pharmacy owner, a pharmacist-in-charge (PIC), or a pharmacy technician actually starts. The claims file a PBM pulls to support a recoupment demand is the same file a federal agent can pull to open a grand jury investigation under the federal healthcare fraud statute, 18 U.S.C. § 1347. The Department of Justice continues to charge pharmacy owners, pharmacists, and technicians nationwide over this kind of billing conduct, and the charges follow a documented pattern already sitting in the claims and purchasing records the pharmacy produced to the PBM.
Billing Patterns That Draw a Fraud Referral
A handful of fact patterns recur in the cases the Department of Justice brings against pharmacies. Billing for prescriptions that were never dispensed, or that a patient never picked up, is the most direct: the claim states the drug left the pharmacy, and the pharmacy's own records say otherwise. Automatic refills the patient never requested create the same gap between the claim and the actual dispensing event. Invoice shortages, where wholesaler purchase records show the pharmacy never bought enough of a drug to support the volume it billed, read to an investigator as proof of phantom claims rather than a bookkeeping lapse. Routine copay waivers can function as a prohibited inducement to the patient under the anti-kickback statute, unless the waiver follows an individualized financial-hardship determination that is not advertised or applied as a matter of course. Payments to marketers or prescribers tied to the volume or value of referrals carry the same exposure, and where the prescriber also holds a financial interest connected to the pharmacy, the conduct can implicate the physician self-referral prohibition under the Stark Law alongside it.
Who Can Be Charged, and Why the Audit File Is the First Exhibit
Liability under 18 U.S.C. § 1347 is not limited to whoever signed the pharmacy's corporate paperwork. The pharmacy owner, the pharmacist-in-charge, and the technicians who entered the claims can each face individual exposure if they knowingly participated, because the statute reaches anyone who knowingly and willfully executed or helped execute the scheme. The PBM audit file becomes the government's first exhibit in these matters, holding exactly what a prosecutor needs: the claims submitted, the dispensing records behind them, and the pharmacy's own responses to the documentation request. Wholesaler purchase records fill the remaining gap, showing what the pharmacy actually bought and when, independent of anything it told the PBM. When the two records disagree, that disagreement becomes the roadmap for a subpoena. A pharmacy already inside an open audit should examine its own file the way the government eventually will, which is why Running an Internal Investigation Without Waiving Privilege belongs earlier in the process, before the audit closes rather than after.
When Agents or a Subpoena Arrive While an Audit Is Open
An open PBM audit does not suspend a parallel law enforcement inquiry. FBI agents, an HHS-OIG subpoena, a grand jury subpoena, or a civil investigative demand can arrive while the PBM's own review is still pending. Do not answer substantive questions from agents without counsel present, and do not alter, delete, or supplement any record once the subpoena or the PBM's documentation request arrives. The pharmacy's obligation to respond to the PBM does not change what is privileged in the parallel criminal inquiry, and the two tracks belong with the same counsel rather than separate ones. Responding to an HHS-OIG Subpoena covers the specific steps for negotiating scope and protecting privilege once a subpoena is in hand.
A PBM audit file and a wholesaler's own purchase records do not need a confession to build a federal healthcare fraud case. They only need to disagree with each other.
Why Early Legal Counsel Is Critical
It is critical that pharmacy owners and pharmacists promptly retain experienced healthcare defense counsel upon receiving a PBM audit documentation request, a subpoena, or a visit from federal agents. Early legal intervention can protect the pharmacy's rights, shape how records are produced before the government draws its own conclusions, avoid inadvertent admissions, and allow counsel to communicate with investigators on the pharmacy's behalf. Delaying representation narrows the pharmacy's options once the claims file and the wholesaler records have already been compared, and the consequences of a conviction, including restitution and forfeiture, reach the individual as well as the business.
How Health Law Alliance Can Help
Health Law Alliance's attorneys have overseen 2,000+ audits and handled 5,000+ matters, with 25+ years of experience.
If your pharmacy is facing a PBM audit that could turn into a referral, or you or your staff have already been contacted by federal agents, contact Health Law Alliance's healthcare fraud defense attorneys for a free, confidential consultation before responding further.
